Literature DB >> 11152679

Protein kinase inhibition by omega-3 fatty acids.

B Mirnikjoo1, S E Brown, H F Kim, L B Marangell, J D Sweatt, E J Weeber.   

Abstract

Recent data suggest that omega-3 fatty acids may be effective in epilepsy, cardiovascular disorders, arthritis, and as mood stabilizers for bipolar disorder; however, the mechanism of action of these compounds is unknown. Based on earlier studies implicating omega-3 fatty acids as inhibitors of protein kinase C activity in intact cells, we hypothesized that omega-3 fatty acids may act through direct inhibition of second messenger-regulated kinases and sought to determine whether the omega-3 double bond might uniquely confer pharmacologic efficacy and potency for fatty acids of this type. In our studies we observed that omega-3 fatty acids inhibited the in vitro activities of cAMP-dependent protein kinase, protein kinase C, Ca(2+)/calmodulin-dependent protein kinase II, and the mitogen-activated protein kinase (MAPK). Our results with a series of long-chain fatty acid structural homologs suggest an important role for the omega-3 double bond in conferring inhibitory efficacy. To assess whether omega-3 fatty acids were capable of inhibiting protein kinases in living neurons, we evaluated their effect on signal transduction pathways in the hippocampus. We found that omega-3 fatty acids could prevent serotonin receptor-induced MAPK activation in hippocampal slice preparations. In addition, we evaluated the effect of omega-3 fatty acids on hippocampal long-term potentiation, a form of synaptic plasticity known to be dependent on protein kinase activation. We observed that omega-3 fatty acids blocked long-term potentiation induction without inhibiting basal synaptic transmission. Overall, our results from both in vitro and live cell preparations suggest that inhibition of second messenger-regulated protein kinases is one locus of action of omega-3 fatty acids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152679     DOI: 10.1074/jbc.M008150200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  The other half of Hebb: K+ channels and the regulation of neuronal excitability in the hippocampus.

Authors:  Laura A Schrader; Anne E Anderson; Andrew W Varga; Michael Levy; J David Sweatt
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

Review 2.  Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment.

Authors:  Vladimir Lerner; Chanoch Miodownik
Journal:  Curr Psychiatry Rep       Date:  2011-08       Impact factor: 5.285

Review 3.  The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.

Authors:  Gerwyn Morris; Ken Walder; Basant K Puri; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

4.  Time of day regulates subcellular trafficking, tripartite synaptic localization, and polyadenylation of the astrocytic Fabp7 mRNA.

Authors:  Jason R Gerstner; William M Vanderheyden; Timothy LaVaute; Cara J Westmark; Labib Rouhana; Allan I Pack; Marv Wickens; Charles F Landry
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

Review 5.  Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology.

Authors:  Robert K McNamara; Jennifer J Vannest; Christina J Valentine
Journal:  World J Psychiatry       Date:  2015-03-22

6.  A prospective study of erythrocyte polyunsaturated fatty acid, weight gain, and risk of becoming overweight or obese in middle-aged and older women.

Authors:  Lu Wang; JoAnn E Manson; Susanne Rautiainen; J Michael Gaziano; Julie E Buring; Michael Y Tsai; Howard D Sesso
Journal:  Eur J Nutr       Date:  2015-03-29       Impact factor: 5.614

Review 7.  COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date.

Authors:  Michael Riedel; Martin Strassnig; Markus J Schwarz; Norbert Müller
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

8.  Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.

Authors:  Massimo F L Pomponi; Giovanni Gambassi; Massimiliano Pomponi; Carlo Masullo
Journal:  Aging Dis       Date:  2010-07-12       Impact factor: 6.745

Review 9.  ER stress and effects of DHA as an ER stress inhibitor.

Authors:  Gulnaz Begum; Lloyd Harvey; C Edward Dixon; Dandan Sun
Journal:  Transl Stroke Res       Date:  2013-08-20       Impact factor: 6.829

10.  Docosahexaenoic acid inhibits protein kinase C translocation/activation and cardiac hypertrophy in rat cardiomyocytes.

Authors:  Alicia Castillo; Nargiz Ruzmetov; Kevin A Harvey; William Stillwell; Gary P Zaloga; Rafat A Siddiqui
Journal:  J Mol Genet Med       Date:  2005-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.